Pentwater Capital Management LP
Q4 2023 13F-HR Holdings
Net value change ($000)
-9,676,906
(-52.0%)
New positions
24
Sold out positions
25
Turnover %
215.9%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q3 2023
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| PIONEER NATURAL RESOURCES CO | 1,313,299 | NEW |
| AHC | 560,062 | NEW |
| X | 493,697 | 3730.0% |
| Karuna Therapeutics, Inc. | 332,644 | 6902.8% |
| SPLUNK INC | 248,090 | 67.0% |
| ImmunoGen, Inc. | 167,893 | NEW |
| CPRI | 147,298 | 274.5% |
| Endeavor Group Holdings, Inc. | 100,141 | NEW |
| AYXGBX | 94,320 | NEW |
| MANU | 87,436 | 44159.6% |
Top Reduces (Value $000, Stocks/ETFs)
| AIY | -2,843,974 | -100.0% |
| Seagen Inc. | -2,732,492 | -100.0% |
| Horizon Therapeutics Public Ltd Co | -1,799,211 | -100.0% |
| VMWA | -652,602 | -100.0% |
| NATIONAL INSTRUMENTS CORP | -266,800 | -100.0% |
| NEW RELIC, INC. | -166,873 | -100.0% |
| DENBURY INC | -114,672 | -100.0% |
| Abcam plc | -97,377 | -100.0% |
| SPY | -96,800 | -53.9% |
| VYX | -73,358 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
3,594,514
(40.3% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|